10,799 Shares in Danaher Corporation $DHR Acquired by OVERSEA CHINESE BANKING Corp Ltd

OVERSEA CHINESE BANKING Corp Ltd purchased a new position in Danaher Corporation (NYSE:DHR – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 10,799 shares of the conglomerate’s stock, valued at approximately $2,055,000.

Several other institutional investors also recently modified their holdings of DHR. High Note Wealth LLC boosted its stake in shares of Danaher by 19.2% during the 4th quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock worth $67,000 after acquiring an additional 47 shares in the last quarter. First Command Advisory Services Inc. raised its position in shares of Danaher by 4.4% during the fourth quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate’s stock worth $253,000 after purchasing an additional 47 shares during the period. GW&K Investment Management LLC raised its position in shares of Danaher by 8.4% during the fourth quarter. GW&K Investment Management LLC now owns 605 shares of the conglomerate’s stock worth $138,000 after purchasing an additional 47 shares during the period. Kestra Private Wealth Services LLC lifted its holdings in shares of Danaher by 0.3% during the third quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate’s stock valued at $3,057,000 after purchasing an additional 48 shares during the last quarter. Finally, SOL Capital Management CO boosted its position in shares of Danaher by 2.7% in the 4th quarter. SOL Capital Management CO now owns 1,879 shares of the conglomerate’s stock valued at $430,000 after purchasing an additional 50 shares during the period. Institutional investors own 79.05% of the company’s stock.

Get Danaher alerts:

Danaher Trading Up 2.2%

NYSE:DHR opened at $216.14 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The stock’s 50-day moving average is $195.01 and its two-hundred day moving average is $192.43. The stock has a market cap of $151.94 billion, a PE ratio of 38.39, a price-to-earnings-growth ratio of 2.63 and a beta of 0.78.

Danaher (NYSE:DHR – Get Free Report) last posted its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The business had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm’s revenue was up 5.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.77 earnings per share. As a group, equities research analysts forecast that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

DHR has been the topic of a number of analyst reports. Weiss Ratings raised Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, July 15th. Wells Fargo & Company reduced their price objective on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a research note on Wednesday, July 22nd. Guggenheim dropped their target price on shares of Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a research report on Wednesday, July 22nd. Wall Street Zen lowered shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, April 25th. Finally, DZ Bank initiated coverage on shares of Danaher in a research note on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 price objective for the company. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and a consensus price target of $228.91.

Check Out Our Latest Report on Danaher

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Recommended Stories

• Five stocks we like better than Danaher
• 3 Energy Stocks Raising Dividends as the Sector Surges
• 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
• Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
• The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.